DNDS Inhibitor

DNDS is a channel blocker of voltage-dependent cystic fibrosis transmembrane conductance regulator (CFTR).

Kramer AH. Statins in the management of aneurysmal subarachnoid hemorrhage: an overview of animal research, observational studies, randomized controlled trials and meta-analyses. Acta Neurochir Suppl. 2011;110(Pt 2):193-201. doi: 10.1007/978-3-7091-0356-2_36. Review. PubMed PMID: 21125471.
Simard JM, Schreibman D, Aldrich EF, Stallmeyer B, Le B, James RF, Beaty N. Unfractionated heparin: multitargeted therapy for delayed neurological deficits induced by subarachnoid hemorrhage. Neurocrit Care. 2010 Dec;13(3):439-49. doi: 10.1007/s12028-010-9435-1. Review. PubMed PMID: 20809188; PubMed Central PMCID: PMC3012204.
Kramer AH, Fletcher JJ. Locally-administered intrathecal thrombolytics following aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Neurocrit Care. 2011 Jun;14(3):489-99. doi: 10.1007/s12028-010-9429-z. Review. PubMed PMID: 20740327.
Singh AK, Venglarik CJ, Bridges RJ. Development of chloride channel modulators. Kidney Int. 1995 Oct;48(4):985-93. Review. PubMed PMID: 8569108.

Small volumes of DNDS, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS5756412 is an inhibitor targeting DNDS.